These effects of HDAC6 inhibition may be relevant for CRC cells as TIM-3 [241], along with PDL-1/2 [207,233], has been identified on tumor cells and has been designated as a negative prognostic biomarker in colon cancer. Here, HDAC6 is linked to neoplasm.